Once-Monthly Galcanezumab for the Prevention of Migraine in Adults: An Evidence-Based Descriptive Review and Potential Place in Therapy

Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s159690
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited


Related search